Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236207 · ClinicalTrials.gov registry record · NA
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
A NA study of Cow Milk Allergy, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 12
- Study locations
NCT03236207 is a NA study of Cow Milk Allergy that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 67 participants. The trial reports 12 study locations across 9 states.
The verdict
NCT03236207, a NA study of Cow Milk Allergy, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 12
- Study locations
Study Summary
Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days.
Conditions Studied
Interventions
- OTHER Test extensively hydrolyzed formula
- OTHER Control extensively hydrolyzed formula
Study Locations (12)
California
- Hoag Medical Group - Huntington Beach
- Stanford University - Mountain View
New York
- Northwell Health System - Great Neck
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Houston Clinical Research Associates - Houston
- Allergy Asthma Research Institute - Waco
Minnesota
- Clinical Research Institute - Plymouth
Missouri
- Midwest Clinical Research - St Louis
New Mexico
- Breathe America - Albuquerque
Oklahoma
- Allergy, Asthma and Clinical Research Center - Oklahoma City
South Carolina
- Carolina ENT - Orangeburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2017-07-06 |
| Est. Completion | 2018-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236207
The ClinicalTrials.gov registry entry for NCT03236207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cow Milk Allergy appearing as the primary indexed condition, and to 2 interventions - of which Test extensively hydrolyzed formula is the first listed.
NCT03236207 reports 12 study locations spanning 9 distinct geographic areas - top geographies include California, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03236207 about?
NCT03236207 is a clinical study titled "Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula". Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days...
What is the current status of trial NCT03236207?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2017-07-06. Estimated completion is 2018-11-06.
What conditions does trial NCT03236207 study?
This clinical trial studies the following conditions: Cow Milk Allergy.
What interventions are being tested in trial NCT03236207?
The interventions under investigation include: Test extensively hydrolyzed formula (OTHER), Control extensively hydrolyzed formula (OTHER).
Who is sponsoring clinical trial NCT03236207?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03236207 being conducted?
This trial has 12 study locations across California, Minnesota, Missouri, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.